Dr. Matthew Bogard, Iowa doctor - CARDIOMEGALY
II. PATHOPHYSIOLOGY
A. Etiology. Ventricular aneurysm and pericardial effusion
can enlarge the cardiac silhouette. However, most cardiac enlargement is due to
pressure overload and muscle hypertrophy of one or more chambers of the heart,
volume overload with dilation of cardiac chambers, or cardiomyopathy. As such,
cardiomegaly is usually the result of other cardiovascular disorders
(hypertension, ischemic or valvular heart disease, familial structural
abnormalities) but can also be caused by systemic diseases (anemia, viral or
rickettsial infections, bite or sting toxins, medications, anabolic steroids
[Ahlgrim], hyperthyroidism, hypothyroidism, hyperparathyroidism, acromegaly
[SCHWARZ] , diabetes, autoimmune and infiltrative (amyloid) diseases, and
metastases). In many cases, particularly with left ventricular hypertrophy,
cardiomegaly is reversible with treatment of the underlying cause.
B. Epidemiology. Cardiomegaly can be an incidental finding
when discovered early in the disease process. It can occur in children and
young adults as a result of rheumatic heart disease, infections, or familial
cardiomyopathies, where the presenting symptom may be sudden death from
arrhythmias, often brought on by physical exertion, as in sports. Left
ventricular mass is increased in obese adolescents (1). Due to the higher
prevalence of ischemia and hypertension, most cases are in older adults.
III. EVALUATION
A. History. Past medical history may include congestive
heart failure, coronary disease, hypertension, rheumatic fever, and systemic
diseases. Family history may reveal hypertension, hyperlipidemia, or sudden
death. Social history might include alcohol or substance abuse or an exposure
to a cardiac toxin. System review could include fatigue, dizziness, dyspnea,
angina, cough, edema, nocturia, and loss of weight with cardiac cachexia, as
well as symptoms more specific to any systemic underlying disease.
B. Physical examination
1. Cardiac. Examination may note a chest deformity causing
apparent cardiomegaly. Inspection may note a visible heave lateral to the
midclavicular line. Palpation of the point of maximal impulse (PMI) below the
fifth intercostal space and lateral to the midclavicular line is highly
specific for left ventricular enlargement, in the absence of chest wall
abnormalities. The PMI may be diffuse (2–3 cm) and may be weak in dilated
cardiomyopathy, or it may be hyperdynamic in increased sympathetic states. The
PMI may be nonpalpable with pericardial effusion. Peripheral pulses may be weak
and pulsus alternans detectable with decreased left ventricular function. If
the PMI cannot be appreciated by palpation, the location of the left border of
the heart can be ascertained by dullness to percussion. Dullness beyond the
midclavicular line and fifth intercostal space is abnormal. Heart murmurs of
abnormal valves responsible for the cardiomegaly may be auscultated, as well as
the regurgitant murmurs resulting from dilated chambers. Diminished heart
sounds or friction rubs may be noted with pericardial disease. S3
and S4 gallops may be heard with heart failure resulting from the
cardiomegaly. Arrhythmias are common with cardiomegaly. Hypertension, as a
cause of cardiomegaly, may be present.
2. Extracardiac. Examination findings may relate to the
underlying causes of cardiomegaly (e.g., autoimmune, infectious, and endocrine
diseases, and alcoholism). The typical extracardiac findings of heart failure
(cough, dyspnea, rales, wheezes, edema, hepatojugular reflux, jugular venous
distension) resulting from the cardiomegaly may also be present.
C. Testing. Cardiomegaly is detectable by chest x-ray,
electrocardiogram (ECG), and echocardiography. Serologic testing primarily
identifies systemic causative disorders, and B-type natriuretic peptide
increases with ventricular wall stretch (2).
1. A standard upright posterior-anterior chest x-ray with
the 10th rib visible at full inspiration in a nonrotated position without chest
deformity is useful for determining the CTR. However, 20% of
echocardiogram-confirmed cases of cardiomegaly are not seen on chest x-ray (2).
Determination of specific chamber enlargement by x-ray is most reliable with
the left atrium, where enlargement projects it posteriorly and superiorly,
resulting in increased cardiac density centrally, displacement of the left main
bronchus superiorly giving it a more horizontal take-off, and a more readily
visible, and curved, left atrial appendage. These findings are significant,
because left atrial enlargement is associated with a poor prognosis and was the
only identified independent predictor of mortality in a cohort of patients with
ischemic cardiomyopathy (3).
2. The ECG is almost always abnormal with cardiomegaly,
although the changes are often nonspecific. The voltage amplitude is often
increased or the axis shifted. Atrial and ventricular arrhythmias are common,
with atrial fibrillation occurring in 25% of patients with cardiomyopathy [HANCOCK].
Because lead V1 is directly over the atria, this lead can best
indicate atrial enlargement. A diphasic P wave in V1 indicates
atrial hypertrophy. In right atrial hypertrophy, the initial half of the wave
is the largest segment. If the second half of the diphasic P wave in lead V1
is larger or wider, there is left atrial hypertrophy. As lead V5 is
over the left ventricle, a tall R wave in V5 indicates left
ventricular hypertrophy. There may be ischemic changes noted on the ECG in
cardiomegaly as well.
3. Echocardiography is the test of choice for a definitive
diagnosis of cardiac enlargement. It can also yield useful information about
systolic and diastolic function, wall hypertrophy, ischemic areas, aneurysms,
pericardial effusion, and the heart valves.[PEWSNER]
D. Genetics. There are familial dilated as well as
obstructive cardiomyopathies and a familial right atrial enlargement. Studies
have indicated that the presence of certain gene alleles can modify the risk of
cardiac hypertrophy (5). Many autoimmune and endocrine causes of cardiomegaly
are known to be familial.
IV. DIAGNOSIS
A. Differential diagnosis. The differential diagnosis of
cardiomegaly consists mainly in distinguishing true from factitious
cardiomegaly due to suboptimal chest x-ray technique. Here the most important
factor is an adequate inspiration revealing the 10th rib. Otherwise, the heart
appears larger and more globular toward the left. Anterior-posterior films and
portable chest x-rays, shot closer than the standard upright view, also falsely
enlarge the heart. Supine views preclude adequate inspiration. Trunk rotation,
scoliosis, and pectus excavatum can cause apparent cardiomegaly.
B. Clinical manifestations. An enlarged heart is less
efficient in providing adequate blood flow to the body and itself. Therefore,
clinical manifestations of cardiomegaly are primarily those of heart failure
(e.g., dyspnea, dizziness, fatigue). Additional symptoms are arrhythmia,
angina, and sudden death. Other manifestations are signs and symptoms
particular to the specific disease causing the cardiomegaly.
References
Damias PG, Tritos
NA. Increased left ventricular mass in obese adolescents. Eur Heart J 2005;26(2):201–202.
Sutter M, Diereks
DB. New insights into decompensated heart failure. Emerg Med 2005:18–25.
Sabharwal N, Cemin
R, Rajan K, et al. Usefulness of left atrial volume as a predictor of mortality
in patients with ischemic cardiomyopathy. Am
J Cardiol 2004;94(6):760–763.
Wenger NK, Abelman
WH, Roberts WC. Cardiomyopathy and specific heart muscle disease. In: Hurst JW,
ed. The heart, arteries, and veins, 7th
ed. New York, NY: McGraw-Hill, 1990:1278–1347.
Dursanoglu D. ACE
polymorphism in healthy young subjects. Acta
Cardiol 2005;60(2): 153–158.
Schwarz, E., Jammula,
P., Gupta, R., & Rosanio, S. (2006). A case and review of
acromegaly-induced cardiomyopathy and the relationship between growth hormone
and heart failure: cause or cure or neither or both?. Journal Of Cardiovascular
Pharmacology And Therapeutics, 11(4), 232-244
Pewsner, D., Jüni, P., Egger, M., Battaglia, M., Sundström,
J., & Bachmann, L. (2007). Accuracy of electrocardiography in diagnosis of
left ventricular hypertrophy in arterial hypertension: systematic review. BMJ
(Clinical Research Ed.), 335(7622), 711.
Hancock, E., Deal, B., Mirvis, D., Okin, P., Kligfield, P.,
Gettes, L., & ... Wellens, H. (2009). AHA/ACCF/HRS recommendations for the
standardization and interpretation of the electrocardiogram: part V:
electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific
statement from the American Heart Association Electrocardiography and
Arrhythmias Committee, Council on Clinical Cardiology; the American College of
Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the
International Society for Computerized Electrocardiology. Journal Of The
American College Of Cardiology, 53(11), 992-1002.
Ahlgrim, C., & Guglin, M. (2009). Anabolics and
cardiomyopathy in a bodybuilder: case report and literature review. Journal
Of Cardiac Failure, 15(6), 496-500.
Originally Published in: Bogard, Matthew. “Cardiomegaly.” Taylor’s 10-Minute Diagnosis Manual. Editors: Paulman, P., Paulman, A., Harrison, J. Lippincott, Williams, & Williams.
*** Dr. Matthew Bogard is an emergency medicine doctor primarily at the Lucas County Health Center in Chariton, Iowa. Presently, he is Board Certified in Family Medicine by the National Board of Physicians and Surgeons and the American Academy of Family Physicians.